Is serum procalcitonin able to predict long-term kidney morbidity from urinary tract infections in children?

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 10, 2008, Pages 1358-1363

  Zaffanello, Marco ^a   Brugnara, Milena ^a   Franchini, Massimo ^b   Fanos, Vassilios ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b Transfusion Service   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Acute pyelonephritis; Children; Procalcitonin; Renal morbidity; Urinary tract infection

Indexed keywords

PROCALCITONIN;

CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FOLLOW UP; HIGH RISK POPULATION; HORMONE BLOOD LEVEL; HUMAN; KIDNEY INJURY; KIDNEY SCINTISCANNING; LONG TERM EXPOSURE; MEDICAL EXAMINATION; META ANALYSIS; MICTURITION CYSTOURETHROGRAPHY; MORBIDITY; PATIENT CODING; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; VESICOURETERAL REFLUX;

CALCITONIN; CHILD; HUMANS; KIDNEY DISEASES; MORBIDITY; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; URINARY TRACT INFECTIONS;

EID: 53849087125     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.282     Document Type: Short Survey

References (28)

1. Jodal U, Lindberg U. Guidelines for management of children with urinary tract infection and vesico-ureteral reflux. Recommendations from a Swedish state-of-the-art conference. Acta Paediatr Suppl 1999;431:87-9.
2. Messer J, Eyer D, Donato L, Gallati H, Matis J, Simeoni U. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr 1996;129:574-80.
3. Jacobson SH, Eklof O, Eriksson CG, Lins LE, Tidgren B, Winberg J. Development of uremia and hypertension after pyelonephritis in childhood: a 27-year follow-up. Br Med J 1989;299:703-6.
4. Risdon RA, Godley ML, Gordon I, Ransley PG. Renal pathology and the 99mTc-DMSA image before and after treatment of the evolving pyelonephritic scar: an experimental study. J Urol 1994;152:1260-6.
5. Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002;20:1-9.
6. Rushton HG, Majd M, Jantaush B, Wiedermann BL, Belman AB. Renal scarring following reflux and non reflux pyelonephritis in children: evaluation with 99mtechnetium-dimercaptosuccinic acid scintigraphy. J Urol 1992;147:1327-32.
7. Hellerstein S. Acute urinary tract infection - evaluation and treatment. Curr Opin Pediatr 2006;18:134-8.
8. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. Br Med J 1999;318:593-6.
9. Cataldi L, Mussap M, Fanos V. Urinary tract infections in infants and children. J Chemother 2006;18:5-8.
10. Pecile P, Romanello C. Procalcitonin and pyelonephritis in children. Curr Opin Infect Dis 2007;20:83-7.
11. van Rossum AM, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis 2004;4:620-30.
12. Benador N, Siegrist CA, Gendrel D, Greder C, Benador D, Assicot M, et al. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics 1998;102:1422-5.
13. Gervaix A, Galetto-Lacour A, Gueron T, Vadas L, Zamora S, Suter S, et al. Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection. Pediatr Infect Dis J 2001;20:507-11.
14. Guven AG, Kazdal HZ, Koyun M, Aydn F, Güngör F, Akman S, et al. Accurate diagnosis of acute pyelonephritis: how helpful is procalcitonin? Nucl Med Commun 2006;27:715-21.
15. Gürgöze MK, Akarsu S, Yilmaz E, Gödekmerdan A, Akça Z, Ciftçi I, et al. Proinflammatory cytokines and procalcitonin in children with acute pyelonephritis. Pediatr Nephrol 2005;20:1445-8.
16. Leroy S, Romanello C, Galetto-Lacour A, Smolkin V, Korczowski B, Rodrigo C, et al. Procalcitonin to reduce the number of unnecessary cystographies in children with a urinary tract infection: a European validation study. J Pediatr 2007;150:89-95.
17. Pecile P, Miorin E, Romanello C, Falleti E, Valent F, Giacomuzzi F, et al. Procalcitonin: a marker of severity of acute pyelonephritis among children. Pediatrics 2004;114:e249-54.
18. Prat C, Domínguez J, Rodrigo C, Giménez M, Azuara M, Jiménez O, et al. Elevated serum procalcitonin values correlate with renal scarring in children with urinary tract infection. Pediatr Infect Dis J 2003;22:438-42.
19. Smolkin V, Koren A, Raz R, Colodner R, Sakran W, Halevy R. Procalcitonin as a marker of acute pyelonephritis in infants and children. Pediatr Nephrol 2002;17:409-12.
20. Tuerlinckx D, Vander Borght T, Glupczynski Y, Galanti L, Roelants V, Krug B, et al. Is procalcitonin a good marker of renal lesion in febrile urinary tract infection? Eur J Pediatr 2005;164:651-2.
21. Bigot S, Leblond P, Foucher C, Hue V, D'Herbomez M, Foulard M. [Usefulness of procalcitonin for the diagnosis of acute pyelonephritis in children]. Arch Pediatr 2005;12:1075-80. In French.
22. Karavanaki K, Angelos Haliotis F, Sourani M, Kariyiannis C, Hantzi E, Zachariadou L, et al. DMSA scintigraphy in febrile urinary tract infections could be omitted in children with low procalcitonin levels. Infect Dis Clin Pract 2007;15:377-81.
23. Leroy S, Adamsbaum C, Marc E, Moulin F, Raymond J, Gendrel D, et al. Procalcitonin as a predictor of vesicoureteral reflux in children with a first febrile urinary tract infection. Pediatrics 2005;115:e706-9.
24. Jaresová M, Stríz I, Cermáková J, Lácha J, Sedlácek J, Mudra K, et al. Serum procalcitonin concentrations in transplant patients with acute rejection and bacterial infections. Immunol Lett 1999;69:355-8.
25. Thayyil S, Shenoy M, Hamaluba M, Gupta A, Frater J, Verber IG. Is procalcitonin useful in early diagnosis of serious bacterial infections in children? Acta Paediatr 2006;94:155-8.
26. Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998;24:888-9.
27. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002;323:17-29.
28. Al Nawas B, Krammer I, Shad PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996;1:331-3.